https://www.selleckchem.com/pr....oducts/buloxibutid.h
5% vs 5.9%) but not statistically significant (P = 0.4). In contrast, the incidence of postoperative atrial fibrillation was lower in the TAVR group (13% vs 29%) but also non-significant (P = 0.2). Finally, the incidence of paravalvular leakage was in favour of the SAVR group (2.9% vs 52%; P = 0.001) while the transfusion requirement was significantly lower in the TAVR group (29% vs 72%; P less then 0.001). Conclusions SAVR utilizing a minimally invasive extracorporeal circuit improves the quality of patient care and can offer an al
Like
Comment
Share
